Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
about
Herbal Medicine for Xerostomia in Cancer Patients: A Systematic Review of Randomized Controlled Trials.AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epitheliumAnticholinergic burden and dry mouth among Finnish, community-dwelling older adults.Retroductal Nanoparticle Injection to the Murine Submandibular Gland.
P2860
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@ast
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@en
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@nl
type
label
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@ast
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@en
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@nl
prefLabel
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@ast
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@en
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@nl
P2860
P50
P3181
P356
P1476
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
@en
P2093
Magí Farré
P2860
P304
P3181
P356
10.7150/IJMS.12912
P407
P577
2015-09-22T00:00:00Z